APA (7th ed.) Citation

SP, F., PG, M., R, Z., S, T., L, W., E, C., . . . RC, D. (2025). Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies. Nature communications, 16(1), 8906. https://doi.org/10.1038/s41467-025-63970-6

Chicago Style (17th ed.) Citation

SP, Fuchs, et al. "Transient Rapamycin Treatment Avoids Unwanted Host Immune Responses Toward AAV-delivered Anti-HIV Antibodies." Nature Communications 16, no. 1 (2025): 8906. https://doi.org/10.1038/s41467-025-63970-6.

MLA (9th ed.) Citation

SP, Fuchs, et al. "Transient Rapamycin Treatment Avoids Unwanted Host Immune Responses Toward AAV-delivered Anti-HIV Antibodies." Nature Communications, vol. 16, no. 1, 2025, p. 8906, https://doi.org/10.1038/s41467-025-63970-6.